Advanced search
Publication Cover
Expert Review of Vaccines Volume 14, 2015 - Issue 12
Submit an article Journal homepage
643
Views
13
CrossRef citations to date
0
Altmetric
Perspective

The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials

Steven BlackCenter for Global Health, Cincinnati Children’s Hospital, 3333 Burnett Avenue, Cincinnati, Ohio 45229, USACorrespondence[email protected]
Pages 1543-1548 | Published online: 28 Sep 2015

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Md Kamal Hossain, Majid Hassanzadeganroudsari, Jack Feehan & Vasso Apostolopoulos. (2022) The race for a COVID-19 vaccine: where are we up to?. Expert Review of Vaccines 21:3, pages 355-376.
Read now

Articles from other publishers (12)

Ottavia Prunas, Joukje E. Willemsen, Louis Bont, Virginia E. Pitzer, Joshua L. WarrenDaniel M. Weinberger. (2023) Incorporating Data from Multiple Endpoints in the Analysis of Clinical Trials: Example from RSV Vaccines. Epidemiology 35:1, pages 103-112.
Crossref
Kiana Shahzamani, Fatemeh Mahmoudian, Shahrzad Ahangarzadeh, Mohammad Mehdi Ranjbar, Leila Beikmohammadi, Samira Bahrami, Elmira Mohammadi, Sahar Esfandyari, Abbas Alibakhshi & Shaghayegh Haghjooy Javanmard. (2021) Vaccine design and delivery approaches for COVID-19. International Immunopharmacology 100, pages 108086.
Crossref
Benoit Hayman, Rajinder Suri & Sai D. Prasad. (2021) COVID-19 vaccine capacity: Challenges and mitigation – The DCVMN perspective. Vaccine 39:35, pages 4932-4937.
Crossref
Pratik Talukder & Sounak Chanda. (2021) RNAi Technology and Investigation on Possible Vaccines to Combat SARS-CoV-2 Infection. Applied Biochemistry and Biotechnology 193:6, pages 1744-1756.
Crossref
Caitlin Dodd, Nick Andrews, Helen Petousis-Harris, Miriam Sturkenboom, Saad B Omer & Steven Black. (2021) Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions. BMJ Global Health 6:Suppl 2, pages e003540.
Crossref
Sanjay Kumar Mishra & Timir Tripathi. (2021) One year update on the COVID-19 pandemic: Where are we now?. Acta Tropica 214, pages 105778.
Crossref
Aaron S. KesselheimJonathan J. DarrowMartin KulldorffBeatrice L. BrownMayookha Mitra-MajumdarChangWon C. LeeOsman MoneerJerry Avorn. (2021) An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19. Health Affairs 40:1, pages 25-32.
Crossref
Daniela Calina, Anca Docea, Demetrios Petrakis, Alex Egorov, Aydar Ishmukhametov, Alexsandr Gabibov, Michael Shtilman, Ronald Kostoff, Félix Carvalho, Marco Vinceti, Demetrios Spandidos & Aristidis Tsatsakis. (2020) Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review). International Journal of Molecular Medicine 46:1, pages 3-16.
Crossref
Gregory A. Tannock, Hyunsuh Kim & Lumin Xue. (2019) Why are vaccines against many human viral diseases still unavailable; an historic perspective?. Journal of Medical Virology 92:2, pages 129-138.
Crossref
Catherine Cohet, Robbert van der Most, Vincent Bauchau, Rafik Bekkat-Berkani, T. Mark Doherty, Anne Schuind, Fernanda Tavares Da Silva, Rino Rappuoli, Nathalie Garçon & Bruce L. Innis. (2019) Safety of AS03-adjuvanted influenza vaccines: A review of the evidence. Vaccine 37:23, pages 3006-3021.
Crossref
Catherine Cohet, Dominique Rosillon, Corinne Willame, Francois Haguinet, Marie-Noëlle Marenne, Sandrine Fontaine, Hubert Buyse, Vincent Bauchau & Laurence Baril. (2017) Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view. Vaccine 35:23, pages 3041-3049.
Crossref
Jesus Reyna-Figueroa, Irina Jeanette Bercholc-Urinowsky, Gabriela Cardoso-Yah, Ricardo Platón Vazquez-Alvarado, Dalila Ramos-López, Freya Helena Campos-Romero, Cory Handelsman & Ana Elena Limón-Rojas. (2017) Evaluation of Adverse Events Following Immunization against Rotavirus Regardless of Recommended Age Restriction. Journal of Biosciences and Medicines 05:08, pages 78-82.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.